Anthropic has released Claude Opus 5.5, a new AI model the company says performs at roughly the same level as its Claude Fable 5.1 model on most work, but at a significantly lower cost.

US artificial intelligence startup Anthropic yesterday unveiled the first discovery from its molecular biology lab, a previously unknown enzyme

Anthropic says its AI Claude autonomously discovered a new CRISPR-like enzyme system, the first result from the company's new wet lab as it

Anthropic released Claude Opus 5.5 on September 22, cutting API pricing 20%. The model matches Claude Fable 5.1's performance and includes safety safeguards.

Anthropic’s latest Claude model brings stronger coding and knowledge capabilities while cutting API costs and adding stricter safeguards.

Anthropic says its AI model has helped identify a previously unknown enzyme system in bacteriophage DNA, with functions that resemble some aspects of CRISPR. The finding emerged from a physical biology lab where human scientists conduct experiments,

A rule Nasdaq wrote this spring could put the Claude maker in index funds within weeks of its debut. SpaceX just showed how small the slice starts.

Anthropic CEO Dario Amodei predicts AI could help cure most diseases in five to 10 years as Claude discovers a potential new gene editing mechanism.